This type of breast cancer is associated with an aggressive disease progression, higher histological grade, poor prognosis, high rate of recurrence and decreased survival rates.
This is most identifiable with prognosis, survival rate and treatment outcome.
Surprisingly, evolution to chronically critical illness did not lead to a worse prognosis: mortality rate was 32%and35%5% for CCI and non-CCI patients, respectively.
Vital prognosis: mortality rates differed across ICU types; 28 to 62% in hospital; and 70% at 1 year (medical and medico-surgical ICUs).
These patients have a poor prognosis; cure rates for patients with MDR tuberculosis and extensively drug-resistant (XDR) tuberculosis globally have been reported to be 48%and22%2%, respectively [ 1].
Sepsis in the presence of cirrhosis is associated with poor prognosis; mortality rates increase with increasing number of failing organs (1, 2).
An evaluation of the class-specific (good versus poor prognosis) error rates for each of the methods revealed that patients with good prognosis were easier to classify than patients with poor prognosis in the melanoma data set.
Many of the tumours in this series may have in fact been esophageal in origin, and this could explain the similarities of the tumours with esophageal adenocarcinoma (e.g. worse prognosis and rates of TP53 mutations).
